Pharma Sector sell off is a buying opportunity last week
Recent earnings disappointments and regulatory concerns have led to a sharp sell-off in Indian pharma stocks, creating an attractive opportunity to build sector exposure amid stabilising US generics dynamics and long-term growth drivers.